MONOGENIC DIABETES
Clinical trials for MONOGENIC DIABETES explained in plain language.
Never miss a new study
Get alerted when new MONOGENIC DIABETES trials appear
Sign up with your email to follow new studies for MONOGENIC DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could tame rare genetic diabetes
Disease control Recruiting nowThis study tests a new drug called dorzagliatin in 44 adults with a rare, inherited form of diabetes (GCK-MODY). The drug works by activating a key enzyme to help the body better control blood sugar. Participants will receive both the drug and a placebo at different times to see …
Matched conditions: MONOGENIC DIABETES
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Massive genetic diabetes hunt launches in china
Knowledge-focused Recruiting nowThis study is creating a large digital registry to find and understand rare forms of diabetes caused by a single gene (monogenic diabetes). Researchers will enroll up to 5,000 people in China who were diagnosed with diabetes at a young age and test their DNA. The goal is to learn…
Matched conditions: MONOGENIC DIABETES
Sponsor: Tianjin Medical University General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Rare genes reveal secrets of diabetes and insulin disorders
Knowledge-focused Recruiting nowThis study looks at people with rare genetic changes that affect beta cells, which control blood sugar. Researchers will collect blood samples and optional MRI scans to find biomarkers and understand how these genes change body function. No treatment is given, and participants co…
Matched conditions: MONOGENIC DIABETES
Sponsor: University of Exeter • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC